Actuate Therapeutics Inc (ACTU)
3.99
-4.09%
Actuate Therapeutics Inc (ACTU) is currently trading at $3.99. This represents a loss of 4.09% from the previous session. With a market capitalization of $0.09B, ACTU is a key component of the Biotechnology sector. Investors looking to trade ACTU should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Get 15 Free Stocks on Moomoo →
T&Cs Apply. Trade ACTU commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, Actuate Therapeutics Inc (ACTU) shows a bearish trend. Analysts are watching the 4.18 level closely.
Fundamentals
Mkt Cap0.09B
P/E Ratio0.0000
Volume10,011
60-Day Technical Chart
Advanced Charting
Need more indicators for ACTU? Use the world's #1 platform.
Open ACTU on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $4
| Metric |
ACTU -4.09% |
UWMC -12.60% |
RXRX +10.48% |
IOVA +1.53% |
|---|---|---|---|---|
| Price | $3.99 | $4.00 | $3.90 | $3.86 |
| Mkt Cap | $0.09B | $6.39B | $2.02B | $1.54B |
| - | View → | View → | View → |
Latest Headlines
Actuate Therapeutics, Inc. to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference on February 26, 2026
Quiver Quantitative • Feb 24, 2026
Actuate Therapeutics, Inc.'s (NASDAQ:ACTU) market cap dropped US$13m last week; Private equity firms bore the brunt
Yahoo Finance • Feb 4, 2026
Actuate Therapeutics, Inc.'s (NASDAQ:ACTU) market cap surged US$24m last week, private equity firms who have a lot riding on the company were rewarded
simplywall.st • Nov 27, 2025
Actuate Therapeutics Announces Proposed Public Offering of Common Stock
GlobeNewswire • Sep 9, 2025
Experimental drug shrinks tough childhood tumors in early trial
Stock Titan • Jan 6, 2026
● Gemini Agentic AI Analyst Insight for ACTU
Market Education
- Stock Valuation Dec 16, 2023
- The Animal Trading Playbook Sep 8, 2025
- These Whales are taking all the Ape money - aka Large Fund Mgmt Companies Jul 17, 2023
External Research